The biotechnology company reported $0.05 EPS for the quarter, beating the consensus estimate of ($0.06) by $0.11. During the same period in the …
The biotechnology company reported $0.05 EPS for the quarter, beating the consensus estimate of ($0.06) by $0.11. During the same period in the …
0 Comments